Drospirenone And Ethinyl Estradiol Kit
Product Images NDC 60505-4897

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Drospirenone And Ethinyl Estradiol (NDC 60505-4897). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Blister (Blister)

DROSPIRENONE AND ETHINYL ESTRADIOL Tablets USP 3 mg/0.03 mg kit containing 28 tablets. The label shows a weekly dosing calendar with spaces for four weeks and days of the week (SUN to SAT). It includes storage instructions at 25°C (77°F) with permitted excursions and safety warnings. Manufactured for Apotex Corp. by Naari Pharma Private Limited, Made in India.*

FDA Label Image

Chart (Chart)

An illustration showing a vertical pregnancy risk scale from fewer pregnancies at the top to more pregnancies at the bottom, listing various birth control methods categorized by effectiveness. At the top are implants, injections, intrauterine devices, and sterilization; followed by birth control pills, skin patch, vaginal ring with hormones, and sterilization; then condoms and diaphragm; followed by no sex during the most fertile days, spermicides, and withdrawal; and at the bottom, no birth control.*

FDA Label Image

Description (Description)

Chemical structure diagrams of Drospirenone and Ethinyl estradiol, the active ingredients in the combined oral contraceptive kit labeled by Apotex Corp.*

FDA Label Image

Figure 1 (Figure 1)

A forest plot comparing hazard ratios, rate ratios, and odds ratios from multiple studies including prospective cohort studies, retrospective cohort studies, case-control studies, and studies of non-fatal idiopathic cases. The studies are listed on the y-axis, with corresponding summary points and confidence intervals plotted on a logarithmic x-axis ranging from 0.1 to 10, centered at 1, indicating relative risk measures with error bars.*

FDA Label Image

Figure 2 (Figure 2)

A horizontal bar chart comparing ranges of an unspecified variable among four groups: Non-Pregnant Non-COC User (1 to 5), COC-User (3 to 9), Pregnancy (5 to 20), and Postpartum (12 weeks only) (40 to 65). Each bar is partially shaded to indicate the lower range with the remainder of the bar indicating the upper range.*

FDA Label Image

Figure 3 (Figure 3)

A forest plot showing odds ratios with confidence intervals for multiple studies related to drospirenone and ethinyl estradiol. The studies are listed on the left, with the odds ratios and confidence intervals plotted as points and lines around a central vertical line representing an odds ratio of 1. This figure compares the risk estimates across different cohorts and studies.*

FDA Label Image

No.of Women (No.of Women)

A horizontal bar chart depicting the number of women with a blood clot out of 10,000 woman years, categorized by different groups: Non-Pregnant Non-COC User, COC-User, Pregnancy, and Postpartum (12 weeks only). Each category is labeled with ranges representing blood clot occurrences.*

FDA Label Image

Outer-carton (Outer Carton)

Packaging label for Drospirenone and Ethinyl Estradiol Tablets USP 3 mg/0.03 mg kit by Apotex Corp. The label includes the NDC 60505-4897 and details that the kit contains 3 blister cards with a total of 28 tablets. It features directions for use, storage instructions, and manufacturer information, along with multiple barcodes and measurement markings for packaging dimensions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.